SCHEMBL23913439

SCHEMBL23913439

c1ccc(-c2ccc3c(c2)oc2cc(-c4nc(-c5cccc(-c6ccc7c(c6)oc6ccccc67)c5)nc(-c5ccc6c(c5)oc5ccccc56)n4)ccc23)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 4/20 0.48
PLA2G4A P47712 4/20 0.48
MMP12 P39900 1/20 0.46
MMP13 P45452 1/20 0.46
AHR P35869 2/20 0.46
MEN1 O00255 2/20 0.45
MAPT P10636 2/20 0.45
KMT2A Q03164 2/20 0.45
HPGD P15428 2/20 0.45
KDM4E B2RXH2 1/20 0.45
ALDH1A1 P00352 1/20 0.45
HCRTR1 O43613 1/20 0.45
PLA2G10 O15496 1/20 0.44
TTR P02766 1/20 0.42
GAA P10253 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
ATM Q13315 1/20 0.40
EPHX2 P34913 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20977616 1.00 PLA2G2A (0.48) PLA2G2APLA2G4AMMP12MMP13AHR
SCHEMBL25852021 1.00 PLA2G2A (0.48) PLA2G2APLA2G4AMMP12MMP13AHR
SCHEMBL21117115 1.00 PLA2G2A (0.48) PLA2G2APLA2G4AMMP12MMP13AHR
SCHEMBL25852032 1.00 PLA2G2A (0.48) PLA2G2APLA2G4AMMP12MMP13AHR
SCHEMBL22763842 1.00 PLA2G2A (0.48) PLA2G2APLA2G4AMMP12MMP13AHR
SCHEMBL20977648 1.00 PLA2G2A (0.48) PLA2G2APLA2G4AMMP12MMP13AHR
SCHEMBL20977643 1.00 PLA2G2A (0.48) PLA2G2APLA2G4AMMP12MMP13AHR
SCHEMBL21029050 0.98 PLA2G2A (0.47) PLA2G2APLA2G4AMMP12MMP13AHR
SCHEMBL24097608 0.98 PLA2G2A (0.47) PLA2G2APLA2G4AMMP12MMP13AHR
SCHEMBL20991469 0.98 PLA2G2A (0.47) PLA2G2APLA2G4AMMP12MMP13AHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210320260-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210320260-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, TRPC1 PLA2G2A 3896/4885PLA2G4A 4007/4885MMP12 4705/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.